Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26114971 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Raghad Buqaileh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA. Hauptthemen laut MEDLINE: Polycystic Kidney Diseases, Cilia, Signal Transduction, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Award.
Abstract (Originalsprache)
Polycystic kidney disease (PKD), a ciliopathy caused primarily by mutations in the Pkd1 and Pkd2 genes, disrupts renal structure and function, leading to progressive renal failure. The primary cilium, a sensory organelle essential for cellular signaling, plays a pivotal role in maintaining renal function. Among its signaling components, G-protein-coupled receptors (GPCRs) within the cilium have gained significant attention for their localized functions and their contribution to PKD pathogenesis. Dysfunction of ciliary GPCR signaling alters key downstream pathways, including mammalian target of rapamycin (mTOR), cyclic adenosine monophosphate (cAMP), and calcium homeostasis, exacerbating cyst formation and disease progression. Additionally, interactions between ciliary GPCRs and PKD-associated proteins, such as Polycystin-1 (PC1) and Polycystin-2 (PC2), underline the complexity of PKD mechanisms. Recent advances highlight GPCRs as promising therapeutic targets for ciliopathies, including PKD. Emerging GPCR modulators and drugs in clinical trials show the potential to restore ciliary signaling and attenuate disease progression. This paper explores the physiological functions of ciliary GPCRs, their mechanistic links to PKD, and the therapeutic implications of targeting these receptors, offering insights into future research directions and therapeutic strategies for PKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.
ORCID-Profile: Lubna A Alshriem, Wissam AbouAlaiwi
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Award
- the University of Toledo Office of Research and Sponsored Programs
- Alzheimer’s Association
- NIA
- NHLBI
Zitieren
APA
Buqaileh, R., Alshriem, L. A., & AbouAlaiwi, W. (2025). Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26114971
Vancouver
Buqaileh R, Alshriem LA, AbouAlaiwi W. Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26114971
BibTeX
@article{Buqaileh2025,
author = {Buqaileh, Raghad and Alshriem, Lubna A and AbouAlaiwi, Wissam},
title = {Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26114971}
}
EUVIMED